Title:
METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS
Document Type and Number:
WIPO Patent Application WO2006014484
Kind Code:
A3
Abstract:
Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye.
More Like This:
WO/2020/206128 | ARTIFICIAL T CELL STIMULATING MATRIX FOR IMMUNOTHERAPY |
JP4451135 | Bioadhesion-oriented somatic cell therapy |
WO/2002/036145 | KAHALALIDE F FORMULATION |
Inventors:
DE JUAN EUGENE (US)
VARNER SIGNE E (US)
LAWIN LAURIE R (US)
VARNER SIGNE E (US)
LAWIN LAURIE R (US)
Application Number:
PCT/US2005/023972
Publication Date:
June 22, 2006
Filing Date:
July 05, 2005
Export Citation:
Assignee:
SURMODICS INC (US)
DE JUAN EUGENE (US)
VARNER SIGNE E (US)
LAWIN LAURIE R (US)
DE JUAN EUGENE (US)
VARNER SIGNE E (US)
LAWIN LAURIE R (US)
International Classes:
A61K9/00; A61F9/00
Foreign References:
US6251090B1 | 2001-06-26 | |||
US5378475A | 1995-01-03 | |||
US5466233A | 1995-11-14 | |||
EP0322319A2 | 1989-06-28 | |||
US20020026176A1 | 2002-02-28 | |||
US6217895B1 | 2001-04-17 |
Download PDF: